Table 1 Patient characteristics at baseline (T0)
Characteristic | Participants who completed tests and questionnaires at T0 (N = 70) | Participants who completed tests and questionnaires at T0 and T1 (N = 58) |
|---|---|---|
Anthropometric data | Â | Â |
 Sex |  |  |
  Male | 15 (21%) | 9 (16%) |
  Female | 55 (79%) | 49 (85%) |
 Age (years) | 53.2 (± 12.8) | 54.1 (± 11.6) |
 Body Mass Index (kg·m− 2) | 27.6 (± 5.6) | 27.5 (± 5.5) |
Cancer type | Â | Â |
 Breast cancer | 27 (39%) | 25 (43%) |
 Hematologic cancer | 12 (17%) | 7 (12%) |
 Cervix carcinoma | 6 (9%) | 4 (7%) |
 Lung cancer | 5 (7%) | 4 (7%) |
 Melanoma | 4 (6%) | 3 (5%) |
 Other | 16 (23%) | 15 (26%) |
Metastasis | Â | Â |
 No metastasis | 37 (53%) | 31 (53%) |
 Lymphatic metastasis | 23 (33%) | 19 (33%) |
 Bone metastasis | 4 (6%) | 3 (5%) |
 Other | 6 (9%) | 5 (9%) |
Treatment | Â | Â |
 Chemotherapy | 49 (70%) | 41 (71%) |
 Surgery | 42 (60%) | 39 (67%) |
 Radiotherapy | 36 (51%) | 31 (53%) |
 Hormone therapy | 19 (27%) | 18 (31%) |
 Immunotherapy | 20 (29%) | 15 (26%) |
 Stem cell transplantation | 6 (9%) | 5 (9%) |
 Treatment completed |  |  |
  Yes | 34 (49%) | 28 (48%) |
  No | 36 (51%) | 30 (52%) |